智財權申請及組合管理
About
貴公司構思出一種尖端產品或一種嶄新的方式推進某種技術。在與世人分享，甚至在全力投資創新概念之前，您有責任與您的團隊和投資人與智財專業人士合作，了解所需的保護措施，制訂在市場上立界擁權的策略。Finnegan飛翰專業同仁在智財法律方面擁有數十年的經驗，從創意發想到獲准及後續都能協助擬訂完整有效的申請策略。除此之外，我們不僅幫助您思考個別發明，也協助您構思可搭配整合的精密智財組合，包括均衡層疊專利和營業秘密，以及商標和著作權的保護。
Practice Areas
Appeals to the PTAB
The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has the authority to hear and adjudicate appeals from applicants on adverse patentability decisions in patent applications and patent reissues and reexaminations.
Copyright
To maintain a competitive advantage, companies and organizations need clear guidance in German, UK, and US intellectual property law and creative solutions to protect their copyrighted works.
設計權利
您的設計使您從競爭中脫穎而出，使您的產品與眾不同，並有助於維持競爭優勢。
單方再審查
Reexamination allows anyone to test the validity of a U.S. patent.
IP Portfolio Management
To be viable and competitive, a company’s business plan must include a comprehensive and proactive intellectual property strategy—investors expect it, and the marketplace demands it.
Patent Drafting and Prosecution
To turn your idea into a valuable asset, you need professionals trained to draft and prosecute patent applications strategically, through a litigation lens, and with the clients’ interests and instructions always at the forefront.
Patent Reissues
Applying for a reissue allows patent owners to correct errors in U.S. patents.
Patent Term Extension (PTE) and Supplementary Protection Certificate (SPC)
If your patented innovation will be developed into a product subject to regulatory approval, the patent life can be extended through Patent Term Extension (PTE) or Supplementary Protection Certificate (SPC).
View Patent Term Extension (PTE) and Supplementary Protection Certificate (SPC)
標準必要專利 (SEPs)
標準必要專利 (SEP) 是一種被納入某特定技術標準的發明。處理標準必要專利的訴訟和授權談判需要特定類型的經驗。
營業秘密
激烈的競爭、員工的異動、企業分拆和新創產業的激增，使營業秘密的保護極為關鍵。
Trademark Counseling and Prosecution
Counseling during the early phases of trademark development helps avoid costly conflicts or enforcement problems down the road.
Experience
Acted for an airport company in LCIA arbitration involving disclosures of confidential information.
Defended a global aerospace and defence company in an ICC arbitration claim on misappropriation of confidential information in breach of a non-disclosure agreement.
Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.
Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client. The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.
IL-2024-000026, UK High Court
Finnegan assists Archer Aviation, a leading urban air mobility company responsible for designing, developing, manufacturing, and operating electric vertical takeoff and landing aircrafts to carry passengers, with strategic global patent prosecution, litigation, enforcement, IP transactions, trade secret counseling, trademark and copyright matters, and competitive intelligence initiatives.